STARTUP PROFILE

Attune Neurosciences

COUNTRY
USA
FOUNDED
2019
CATEGORY
Neuromodulation
Developing wearable low-intensity focused ultrasound neuromodulation systems for deep-brain targets across chronic pain, depression, and related indications.
Visit website →
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
Ultrasound
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Attune Neurosciences sits in the focused ultrasound neuromodulation segment, with a wearable headband format aimed at making deep-brain stimulation more deployable outside hospital-based systems. Its current positioning is clinical-stage and research-backed, with ARPA-H supported work in chronic pain and depression biomarkers.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Attune Neurosciences
No items found.